American International Group’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,691
| Closed | -$120K | – | 2604 |
|
|
2024
Q1 | $120K | Sell |
1,691
-15
| -0.9% | -$1.13K | ﹤0.01% | 2412 |
|
|
2023
Q4 | $144K | Sell |
1,706
-6
| -0.4% | -$498 | ﹤0.01% | 2355 |
|
|
2023
Q3 | $147K | Buy |
1,712
+61
| +4% | +$5.63K | ﹤0.01% | 2286 |
|
|
2023
Q2 | $154K | Sell |
1,651
-12
| -0.7% | -$1.13K | ﹤0.01% | 2327 |
|
|
2023
Q1 | $158K | Buy |
1,663
+34
| +2% | +$3.13K | ﹤0.01% | 2249 |
|
|
2022
Q4 | $164K | Sell |
1,629
-6
| -0.4% | -$548 | ﹤0.01% | 2244 |
|
|
2022
Q3 | $139K | Buy |
1,635
+23
| +1% | +$2.03K | ﹤0.01% | 2376 |
|
|
2022
Q2 | $138K | Sell |
1,612
-89
| -5% | -$7.59K | ﹤0.01% | 2406 |
|
|
2022
Q1 | $153K | Sell |
1,701
-119
| -7% | -$10.9K | ﹤0.01% | 2400 |
|
|
2021
Q4 | $182K | Sell |
1,820
-55
| -3% | -$5.61K | ﹤0.01% | 2430 |
|
|
2021
Q3 | $174K | Sell |
1,875
-44
| -2% | -$3.89K | ﹤0.01% | 2505 |
|
|
2021
Q2 | $163 | Sell |
1,919
-71
| -4% | -$6.14K | ﹤0.01% | 2635 |
|
|
2021
Q1 | $172 | Buy |
1,990
+5
| +0.3% | +$440 | ﹤0.01% | 2444 |
|
|
2020
Q4 | $167 | Sell |
1,985
-56
| -3% | -$4.77K | ﹤0.01% | 2373 |
|
|
2020
Q3 | $163K | Sell |
2,041
-47
| -2% | -$3.9K | ﹤0.01% | 2260 |
|
|
2020
Q2 | $185K | Buy |
2,088
+27
| +1% | +$2.42K | ﹤0.01% | 2167 |
|
|
2020
Q1 | $194K | Sell |
2,061
-119
| -5% | -$11.1K | ﹤0.01% | 1917 |
|
|
2019
Q4 | $235K | Sell |
2,180
-18
| -0.8% | -$1.82K | ﹤0.01% | 2119 |
|
|
2019
Q3 | $211K | Sell |
2,198
-15
| -0.7% | -$1.39K | ﹤0.01% | 2132 |
|
|
2019
Q2 | $212K | Buy |
2,213
+22
| +1% | +$1.85K | ﹤0.01% | 2189 |
|
|
2019
Q1 | $193K | Sell |
2,191
-71
| -3% | -$6.24K | ﹤0.01% | 2228 |
|
|
2018
Q4 | $188K | Sell |
2,262
-17
| -0.7% | -$1.5K | ﹤0.01% | 2217 |
|
|
2018
Q3 | $215K | Buy |
2,279
+41
| +2% | +$3.92K | ﹤0.01% | 2379 |
|
|
2018
Q2 | $247K | Buy |
2,238
+54
| +2% | +$5.64K | ﹤0.01% | 2237 |
|
|
2018
Q1 | $216K | Sell |
2,184
-116
| -5% | -$10.3K | ﹤0.01% | 2213 |
|
|
2017
Q4 | $187K | Buy |
2,300
+11
| +0.5% | +$859 | ﹤0.01% | 2363 |
|
|
2017
Q3 | $168K | Buy |
2,289
+171
| +8% | +$12.3K | ﹤0.01% | 2378 |
|
|
2017
Q2 | $153K | Buy |
2,118
+3
| +0.1% | +$197 | ﹤0.01% | 2443 |
|
|
2017
Q1 | $132K | Buy |
2,115
+138
| +7% | +$8.69K | ﹤0.01% | 2440 |
|
|
2016
Q4 | $144K | Sell |
1,977
-6
| -0.3% | -$390 | ﹤0.01% | 2379 |
|
|
2016
Q3 | $119K | Buy |
1,983
+3
| +0.2% | +$191 | ﹤0.01% | 2508 |
|
|
2016
Q2 | $125K | Sell |
1,980
-217
| -10% | -$14K | ﹤0.01% | 2444 |
|
|
2016
Q1 | $137K | Hold |
2,197
| – | – | ﹤0.01% | 3130 |
|
|
2015
Q4 | $129K | Sell |
2,197
-4
| -0.2% | -$227 | ﹤0.01% | 3269 |
|
|
2015
Q3 | $119K | Buy |
2,201
+2
| +0.1% | +$109 | ﹤0.01% | 3337 |
|
|
2015
Q2 | $131K | Sell |
2,199
-165
| -7% | -$9.29K | ﹤0.01% | 3431 |
|
|
2015
Q1 | $142K | Hold |
2,364
| – | – | ﹤0.01% | 3274 |
|
|
2014
Q4 | $142K | Sell |
2,364
-93
| -4% | -$5.15K | ﹤0.01% | 3260 |
|
|
2014
Q3 | $120K | Sell |
2,457
-2
| -0.1% | -$102 | ﹤0.01% | 3409 |
|
|
2014
Q2 | $126K | Buy |
2,459
+208
| +9% | +$10.7K | ﹤0.01% | 3404 |
|
|
2014
Q1 | $130K | Buy |
2,251
+54
| +2% | +$2.95K | ﹤0.01% | 3221 |
|
|
2013
Q4 | $126K | Sell |
2,197
-22
| -1% | -$1.21K | ﹤0.01% | 3165 |
|
|
2013
Q3 | $132K | Sell |
2,219
-42
| -2% | -$2.29K | ﹤0.01% | 3094 |
|
|
2013
Q2 | $123K | Buy |
+2,261
| New | +$106K | ﹤0.01% | 2979 |
|
Other funds holding UTMD
BIP
RIM
RHJA
American International Group's UTMD Position: Q2 2024 in Review
American International Group sold out of Utah Medical Products (UTMD) in Q2 2024, closing a stake of 1,691 shares — an estimated $120K sold.
American International Group first reported a position in UTMD in Q2 2013 and held it in 44 quarters. The position peaked at $247K in Q2 2018. 100 funds tracked by Wall St. Rank hold UTMD as of Q2 2024.
- American International Group reported no remaining Utah Medical Products position as of Q2 2024 after selling out during the quarter.
- American International Group sold 1,691 Utah Medical Products shares in Q2 2024, an estimated $120K.
- American International Group first reported a position in Utah Medical Products in Q2 2013 and held it in 44 quarters.
- American International Group's Utah Medical Products position peaked at $247K in Q2 2018.
- 100 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.